# GeneXtend, LLC – FDA Inspection, Aug 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/genextend-llc/ddaed345-a1ec-4042-93bf-ad693ec786ec
Source feed: FDA_Inspections

> FDA inspection 1062807 of GeneXtend, LLC, August 17, 2018. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 1271. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062807
- Company Name: GeneXtend, LLC
- Inspection Date: 2018-08-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1217689 - 2023-09-13](https://www.keypedia.com/records/fda_inspections/genextend-llc/73998613-91c5-4132-a110-84df3288d026)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/genextend-llc/efa8624c-2ecb-4d56-804e-f40847f55404

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d